Transfection and Physical Properties of Various Saccharide, Poly(ethylene glycol), and Antibody-Derivatized Polyethylenimines (PEI)

Journal of Gene Medicine

Volumn 1, Issue 3, 1999, Pages 210-222

  Erbacher, Patrick ^a   Bettinger, Thierry ^a   Belguise Valladier, Pascale ^a   Zou, Shaomin ^a   Coll, Jean Luc ^b   Behr, Jean Paul ^a   Remy, Jean Serge ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT ALBERT BONNIOT   (France)

Author keywords

Antibody; Gene transfer; Poly(ethylene glycol); Polyethylenimine; Saccharide residues

Indexed keywords

ANTIBODY; CARBOHYDRATE; DEXTRAN; DRUG DERIVATIVE; MACROGOL DERIVATIVE; MALTOSE; POLYETHYLENEIMINE; RECOMBINANT DNA;

ANIMAL; ARTICLE; CELL LINE; ELECTRON MICROSCOPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; MOUSE;

ANIMALS; ANTIBODIES; CARBOHYDRATES; CELL LINE; DEXTRANS; DNA, RECOMBINANT; GENETIC VECTORS; HELA CELLS; HUMANS; MALTOSE; MICE; MICROSCOPY, ELECTRON; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 0033122034     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-2254(199905/06)1:3<210::aid-jgm30>3.0.co;2-u     Document Type: Article

References (61)

1. Crystal RG. Transfer of genes to humans: Early lessons and obstacles to success. Science 1995; 270: 404-410.
2. Hong KL, Zheng WW, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 1997; 400: 233-237.
3. Toncheva V, Wolfert MA, Dash PR, et al. Novel Vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim Biophys Acta 1998; 1380: 354-368.
4. Vinogradov SV, Bronich TK, Kabanov AV. Self-assembly of polyamine-Poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug Chem 1998; 9: 805-812.
5. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
6. Labatmoleur F, Steffan AM, Brisson C, et al. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther 1996; 3: 1010-1017.
7. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
8. Ledley FD. Pharmaceutical approach to somatic gene therapy. Pharm Res 1996; 13: 1595-1614.
9. Wagner E, Cotten M, Foisner R, Birnstiel ML. Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci U S A 1991; 88: 4255-4259.
10. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997; 4: 823-832.
11. Dunlap DD, Maggi A, Soria MR, Monaco L. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res 1997; 25: 3095-3101.
12. Feigner PL, Barenholz Y, Behr JP, et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997; 8: 511-512.
13. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A 1996; 93: 12349-12354.
14. Plank C, Mechtler K, Szoka FC, Wagner E. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
15. Boussif O, Lezoualch F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
16. Abdallah B, Hassan A, Benoist C, et al. A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum Gene Ther 1996; 7: 1947-1954.
17. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074-1080.
18. MeunierDurmort C, Grimal H, Sachs LM, Demeneix BA, Forest C. Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells. Gene Ther 1997; 4: 808-814.
19. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI-DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 172-177.
20. Goula D, Benoist C, Mantero S, et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 1998; 5: 1291-1295.
21. Behr JP. The proton sponge, a means to enter cells viruses never thought of. M/S-Med Sci 1996; 12: 56-58.
22. Kichler A, Erbacher P, Behr JP. Polyethylenimines: a family of potent polymers for nucleic acid delivery. In Non-Viral Vectors for Gene Therapy, In: Huang L, Hung M, Wagner E. San Diego, CA, USA: Academic press, in press.
23. Kircheis R, Kichler A, Wallner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997; 4: 409-418.
24. Zanta MA, Boussif O, Adib A, Behr JP. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997; 8: 839-844.
25. Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998; 4: 285-290.
26. Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther 1999; 6: 138-145.
27. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem 1992; 3: 533-539.
28. Monsigny M, Petit C, Roche AC. Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. Anal Biochem 1988; 175: 525-530.
29. Snyder SL, Sobocinski PZ. An improved 2,4,6-trinitrobenzene-sulfonic acid method for the determination of amines. Anal Biochem 1975; 64: 284-288.
30. Carlsson J, Drevin H, Axén R. N-succinimidyl 3-(2-pyridyl-dithio)propionate, a new heterobifunctional reagent. Biochem J 1978; 173: 723-737.
31. Buschle M, Cotten M, Kirlappos H, et al. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther 1995; 6: 753-761.
32. Erbacher P, Zou S, Bettinger T, Remy JS. Chitosan-based vector/ DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332-1339.
33. Erbacher P, Roche AC, Monsigny M, Midoux P. Glycosylated polylysine/DNA complexes: Gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjug Chem 1995; 6: 401-410.
34. Lasic DD, Papahadjopoulos D. Liposomes revisited. Science 1995; 267: 1275-1276.
35. Zalipsky S. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug Chem 1995; 6: 150-165.
36. Harford J, Ashwell G. The hepatic receptor for asialoglycoproteins. In The Glycoconjugates, In: Horowitz MI (ed). New-York: Academic Press, 1982.
37. Cristiano RJ, Curiel DT. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther 1996; 3: 49-57.
38. Mueller BM, Romerdahl CA, Gillies SD, Reisfeld RA. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. J Immunol 1990; 144: 1382-1386.
39. Gross N, Beck D, Favre S, Carrel S. In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP. Int J Cancer 1987; 39: 521-529.
40. Mujoo K, Cheresh DA, Yang HM, Reisfeld RA. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res 1987; 47: 1098-1104.
41. Suh J, Paik HJ, Hwang BK. Ionization of poly(ethylenimine) and poly(allylamine) at various pH's. Bioorg Chem 1994; 22: 318-327.
42. Ogris M, Steinlein P, Kursa M, et al. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425-1433.
43. Wadhwa MS, Collard WT, Adami RC, McKenzie DL, Rice KG. Peptide-mediated gene delivery: Influence of peptide structure on gene expression. Bioconjug Chem 1997; 8: 81-88.
44. Maruyama A, Ishihara T, Kim JS, Kim SW, Akaike T. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). Bioconjug Chem 1997; 8: 735-742.
45. Allen TM, Hansen C, Martin F, Redemann C, Yauyoung A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29-36.
46. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation - studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991; 1062: 77-82.
47. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1991; 1062: 142-148.
48. Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994; 15: 215-220.
49. Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes - improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Nat Aca Sci U S A 1991; 88: 11460-11464.
50. Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymercoated liposome longevity. Biochim Biophys Acta 1994; 1195: 11-20.
51. Mori A, Klibanov AL, Torchilin VP, and Huang L. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett 1991; 284: 263-266.
52. Blume G, Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1993; 1146: 157-168.
53. Wolfert MA, Schacht EH, Toncheva V, et al. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum Gene Ther 1996; 7: 2123-2133.
54. Katayose S, Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethylene glycol) -poly(L-lysine) block copolymer. Bioconjug Chem 1997; 8: 702-707.
55. Remy JS. Synthèse et utilisation in vitro de nouveaux vecteurs de transfert de gènes. PhD Thesis, 1994. Université Louis Pasteur, Strasbourg.
56. Lee YC, Towndsend RR, Hardy MR, et al. Binding of synthetic oligosaccharides to hepatic Gal/GalNAc lectin. Dependent on fine structural features. J Biol Chem 1983; 258: 199-202.
57. Bettinger T, Remy JS, Erbacher P, Behr JP. Convenient polymer-supported synthetic route to heterobifunctional polyethylene glycols. Bioconjug Chem 1998; 9: 842-846.
58. Trubetskoy VS, Torchilin VP, Kennel SJ, Huang L. Use of N-terminal modified poly(L-lysine) antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. Bioconjug Chem 1992; 3: 323-327.
59. Thurnher M, Wagner E, Clausen H, et al. Carbohydrate receptor-mediated gene transfer to human T leukaemic cells. Glycobiology 1994; 4: 429-435.
60. Coll JL, Combaret V, Metchler K, et al. In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer. Gene Ther 1997; 4: 156-161.
61. Bettinger T, Remy JS, Erbacher P. Size reduction of galactosy-lated PEI/DNA complexes improves lactin-mediated gene transfer. Bioconjug Chem 1999; in press.